NEC CTO & Netcracker CEO Deliver Keynote Address on the Future of Generative AI [NEC Official]

It is a great honor for me to cover this session on the future of generative AI in business. We will soon welcome on stage our speakers. They are leaders within their industries and they will share their experience with generative AI. So Andrew and Motoo, welcome on stage.

Cancer is an incredibly complex and intelligent disease. While standard treatments can work well for some patients, they can be ineffective or even lethal for others with the same diagnosis. Boston Gene powers healthcare's transition to personalized medicine using artificial intelligence-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. As a global diversified conglomerate, NEC plays a pivotal role across different industries ranging from telecom to healthcare, from drug discovery to financial services, mitigating natural disasters to ensuring children have adequate vaccinations. NEC provides infrastructure that brings people together and improves their lives. Netcracker partners with technology innovators to enable business and technology journeys that will transform telcos into techcos. Netcracker Solutions leverage artificial intelligence and big data analytics powered by Cloud-native software and Professional Services in every part of the world. With an unbroken delivery record and the largest investment in innovation in the industry, Netcracker is helping our customers accelerate digital growth and profitability.

Thank you, thank you for inviting me to join you on stage. I am incredibly privileged to be involved with two companies: one is a telecom operations and business support company, another one is the personalized cancer diagnostic and treatment company. And you would ask what do those two companies have in common? The reality is both are AI-driven software companies. I'll come back to this in a minute but first let me give you some examples of what each of these companies does. I'd like to start by introducing you to Glenn. Glenn is a very real 58-year-old male who lives in New York who in October of 2020 was diagnosed with small cell lung cancer. What you see behind me is a PET scan: black spots is cancer, and what you see is lung cancer that metastasized into liver, kidneys, lymph nodes, and many other organs. As you can see at the line below, Glenn had gone through a number of treatments, very toxic, very potent treatments, but unfortunately for a year and a half there was no result. He then joined a clinical trial which was not successful. At that point, Boston Gene got a very simple, very small sample of Glenn's tissue. We examined that tissue through very sophisticated molecular diagnostics but then most importantly we ran it through our AI-driven cloud platform that correlated our findings with everything known to man, petabytes of information of all of the treatments, all of the biological mutations, all of the publications, all of the trials. And we realized that Glenn was in fact a victim of a very unique mutation that is almost never seen in lung cancer but is very tightly associated with a particular therapy. And as you can see we recommended that therapy to the physician. Glenn went on the therapy and he had been cancer-free now for years because of that. And he almost certainly would have died had it not been for AI involvement and Boston Gene involvement in his treatment. You see on the right hand side is a clean PET scan: there is no black, the black that you see out there is his heart, it's okay, a human should have a heart and that's what it should look like on a PET scan. At Netcracker, while we're not saving lives, we have been working with AI-driven solutions for a very long time, long before ChatGPT became so popular. And we are seeing incredible benefits in very real use cases where we're able to derive very tangible, very manageable, very measurable, very quantifiable KPIs. Primarily of course today we focus on sales and sales channels, but we're seeing benefits all the way through operations into network provisioning and disaster recovery. And as you can see based on a number of very real implementations that we're measuring on a daily basis, we are deriving very significant benefits with great business cases on all layers of operations from customer journey to network management with both cost savings and efficiency, as well as more and more revenue upsides by bringing different products, by selling more efficiently, and of course by targeting more channels. This is the power of AI. But what's really important, this is the power of AI that lives on top of very sophisticated digital platforms that truly understand where the data is, how the data is structured, that truly understand the business and customer profiles of each infrastructure, and are deployed in a very secure and very sustainable manner. This is digital transformation. This is the benefit we have derived having gone through digital transformation. Then we are able to enable our customers to deploy these cognitive solutions to bring to life those benefits that range from significant, quantitatively measurable returns to, in some cases as you saw, life-saving opportunities. So my parting thoughts to you is that while AI is remarkably powerful and there's no doubt that it's going to change the world and it is changing the world as you see as we speak, but AI by itself is not a silver bullet. There is no magic pill. We're still driving digital transformation, we're still understanding how to deploy it in a sustainable and secure manner. And those who are able to do this are evolving as winners and becoming incredibly successful. Thank you.